STARKVILLE — Sano Chemical, the company launched to develop an antifungal drug discovered at Mississippi State University, has received the university’s Faculty Start-up Company of the Year.
Dr. Stephen Pruett, basic sciences department head at MSU’s College of Veterinary Medicine, said the award was given by the Office of Entrepreneurship and Technology Transfer at the I3, or Investing in Innovation, conference. Dr. Frank Austin, CVM associate professor, received the award on behalf of James Smith, an adjunct professor at CVM and a professor at Texas A&M University and; Dr. Shien Lu, Mississippi Agricultural and Forestry Experiment Station researcher; and Pruett, who collaborated with Sano Chemical on toxicology studies.
“The company was formed about two years ago to develop the antifungal compound occidiofungin,” Pruett said. “We are continuing research at MSU to develop different uses of the compound and are pursuing funding to continue the development research of this compound.”
The potential drug shows significant promise for the treatment of serious fungal infections in people with compromised immune systems, such as those undergoing chemotherapy treatments and those with HIV or AIDS. While MSU holds numerous patents and licenses, this is the first time a potential pharmaceutical drug has emerged from MSU research.
Sano Chemical is in the preclinical stages of research on this compound and has published several papers on the subject.
BEFORE YOU GO…
… we’d like to ask for your support. More people are reading the Mississippi Business Journal than ever before, but advertising revenues for all conventional media are falling fast. Unlike many, we do not use a pay wall, because we want to continue providing Mississippi’s most comprehensive business news each and every day. But that takes time, money and hard work. We do it because it is important to us … and equally important to you, if you value the flow of trustworthy news and information which have always kept America strong and free for more than 200 years.
If those who read our content will help fund it, we can continue to bring you the very best in news and information. Please consider joining us as a valued member, or if you prefer, make a one-time contribution.Click for more info